KLOW (80mg) Dosage Protocol
KLOW is an advanced regenerative blend combining KPV (20mg), LL-37 (10mg), Oxytocin (10mg), and Wolverine (BPC-157 20mg + TB-500 20mg). Designed for comprehensive healing, immune support, and tissue regeneration.
Add 3.0 mL bacteriostatic water → 26.7 mg/mL total
500-1000 mcg total blend daily
At 26.7 mg/mL: 2 units = 534 mcg, 4 units = 1068 mcg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 3 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-2 | 500 mcg daily | 2.5 units |
| Weeks 3-4 | 750 mcg daily | 3.75 units |
| Weeks 5-8 | 1000 mcg daily | 5 units |
- 1Draw 3.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - may take longer due to complexity
- 4Label with date and concentration, refrigerate immediately
KLOW combines five peptides with complementary mechanisms: KPV (alpha-MSH fragment) provides potent anti-inflammatory effects through NF-κB modulation. LL-37 is an antimicrobial peptide supporting immune defense. Oxytocin supports tissue repair and has anti-inflammatory properties. BPC-157 and TB-500 (Wolverine) provide comprehensive tissue healing support.
- Multi-pathway healing and immune support
- KPV for inflammation control
- LL-37 for antimicrobial defense
- Oxytocin for tissue repair
- BPC-157 + TB-500 for comprehensive healing
- Brzoska T, et al. Alpha-MSH and KPV. Endocr Rev. 2008
- Vandamme D, et al. LL-37 antimicrobial peptide. Cell Immunol. 2012
- Sikiric P, et al. BPC-157 healing. Front Pharmacol. 2021
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 3 weeks
Complex blend - allow extra time for dissolution
- •Research compounds - not FDA approved
- •Complex blend requires careful reconstitution
- •Start with lower dose and titrate up
- •Monitor for any sensitivity reactions
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.